Parkinson’s News Today

June 21, 2022June 21, 2022

Speech Problems Evident in Vocal Tract Length Might ID Parkinson’s

Analyses that estimate the length of a person’s vocal tract, which involves controlling muscles used in speech, could help to identify Parkinson’s disease, according to a new study. “The standard ... Read more

June 21, 2022June 21, 2022

Changes in Brain Architecture Tied To Poor Bimanual Coordination

Parkinson's News Today

Small-scale, or microstructural, brain alterations observed on the MRIs of people with Parkinson’s disease were associated with worse bimanual coordination, a type of complex movement, a study found. “istinct changes ... Read more

June 20, 2022June 20, 2022

App for Voice ‘Games’ May Aid At-home Speech Therapy Practice

Parkinson's News Today

Researchers have proposed a set of voice exercise games to help speech quality in people with Parkinson’s disease, which licensed speech therapists found to be a generally feasible, promising approach. ... Read more

June 20, 2022June 20, 2022

Gut Microbiome of Patients Favors Inflammation, Study Suggests

Parkinson's News Today

People with Parkinson’s disease appear to have a gut microbiome — the population of microorganisms living in the intestines — that is shifted toward a pro-inflammatory state, a small study ... Read more

June 17, 2022June 17, 2022

Inbrija, Inhaled Levodopa for ‘Off’ Episodes, Launches in Germany

Parkinson's News Today

Inbrija, an approved treatment for “off” episodes of Parkinson’s disease, has now been launched in Germany. The medication is being sold in Germany by Esteve Pharmaceuticals under an agreement with ... Read more

June 17, 2022June 18, 2022

Study Planned to Assess Severity of Speech Symptoms

Parkinson's News Today

The healthcare technology company Koneksa and Northwestern University plan to begin recruiting patients in the third quarter of this year for a study aimed at measuring the severity of vocal ... Read more

June 16, 2022June 17, 2022

Companies Partner on Tech for Finding Best Time to Take Medication

Parkinson's News Today

Two European pharma companies have teamed up to create a technology platform that will help people with Parkinson’s disease find the best time to take their medication and make personalized ... Read more

June 16, 2022June 16, 2022

Scientists Discover How to Turn Stem Cells Into Dopaminergic Neurons

Parkinson's News Today

A new method for turning specific human stem cells, called pluripotent stem cells, into neurons that can produce dopamine — the signaling molecule, essential for controlling movement, that is missing ... Read more

June 15, 2022June 16, 2022

Trial of Fibroblast Growth Factor-1 Shows Safety, Suggests Efficacy

Parkinson's News Today

A first study in patients of an intranasal-delivered therapy for Parkinson’s disease is now complete, and early findings support the treatment being safe and leading to improvements in motor function, ... Read more

June 15, 2022June 15, 2022

New Role for Alpha-synuclein Uncovered by Researchers

Parkinson's News Today

The buildup of alpha-synuclein in cells and brain tissue in Parkinson’s disease patients is linked to the disruption of processes involved in degrading RNA, the template used for protein production, ... Read more

June 14, 2022June 14, 2022

Trial to Test Wearable ‘Exoskeleton’ as Training Aid for Gait Problems

Parkinson's News Today

A clinical trial will evaluate how well a wearable “exoskeleton” device aids rehabilitation training to improve walking mechanics and neuromuscular function in people with Parkinson’s disease. “Findings linked with the proposed study ... Read more

June 14, 2022June 14, 2022

StrivePD App to Monitor Symptoms Via Apple Watch Cleared by FDA

Parkinson's News Today

StrivePD, a Rune Labs‘ app that collects motor symptom data for people with Parkinson’s disease via measurements recorded by an Apple Watch, has been cleared for use by the U.S. Food ... Read more

June 13, 2022June 13, 2022

Biogen and Alectos Team Up to Advance AL01811 for Parkinson’s

Parkinson's News Today

Biogen and Alectos Therapeutics have signed an exclusive license and collaboration agreement to further develop and commercialize AL01811, a small molecule therapy, as a potential treatment for Parkinson’s disease. “Through ... Read more

June 13, 2022June 13, 2022

‘Off’ Episodes May Affect 1 in 3 Patients Come Bedtime, Trials Find

Parkinson's News Today

About 1 in 3 Parkinson’s disease patients in two Phase 3 trials experienced an “off” episode before going to sleep, and most of those who woke up during the night were in ... Read more

June 10, 2022June 10, 2022

NeuroString Sensor Measures Neurotransmitter Activity

Parkinson's News Today

A soft, stretchable sensor called NeuroString could be used for measuring the activity of neurotransmitters — chemical messengers that nerve cells use to communicate — in the bodies of living ... Read more